Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
As of: Nov 16, 2026 · 3:32 PM EST

Amneal Pharmaceuticals (AMRX) Gross Margin (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Gross Margin of 38.73% for Q3 2026, up 3.81 percentage points from 34.92% a year earlier but down 3.28 percentage points from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Gross Margin (2017 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Gross Margin at Amneal Pharmaceuticals was 40.24%, up 3.48 percentage points year-over-year; for FY2025, it was 36.88%, up 0.36 percentage points from FY2024.

  • Annual Gross Margin shows a five-year change of +5.34 percentage points (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Gross Margin was 36.52% in FY2024 (+2.24 pp), 34.28% in FY2023 (-1.19 pp), 35.47% in FY2022 (-1.26 pp) and 36.73% in FY2021 (+5.19 pp).
  • Quarterly Gross Margin has run from a low of 30.77% in Q4 2023 to a high of 44.31% in Q1 2026 over five years.
  • On a year-over-year basis, Gross Margin has increased in each of the last four quarters, with an average year-over-year change of +2.58 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q1 2026, with a gain of 7.51 percentage points; the weakest was Q4 2023, with a drop of 4.56 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 42.01% (Q2 2026), 44.31% (Q1 2026) and 36.50% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,281.55 Bn 1,255.17 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 683.70 Bn 603.56 Bn 17.30 Bn 68.12%
3 AbbVie 521.54 Bn 489.55 Bn 13.12 Bn 75.38%
4 Merck 359.91 Bn 322.85 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.69 Bn 284.93 Bn - -
6 Astrazeneca 286.04 Bn 259.69 Bn 13.26 Bn 88.03%
7 Amgen 250.76 Bn 202.42 Bn 7.58 Bn 73.10%
8 Gilead Sciences 208.18 Bn 183.29 Bn 6.73 Bn 81.07%
9 Pfizer 164.82 Bn 112.17 Bn 12.56 Bn 75.71%
10 Amneal Pharmaceuticals 7.13 Bn 6.37 Bn 334.12 Mn 38.73%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 38.73%
Jun 30, 2026 42.01%
Mar 31, 2026 44.31%
Dec 31, 2025 36.50%
Sep 30, 2025 34.92%
Jun 30, 2025 39.51%
Mar 31, 2025 36.80%
Dec 31, 2024 35.98%
Sep 30, 2024 38.37%
Jun 30, 2024 35.62%
Mar 31, 2024 36.11%
Dec 31, 2023 30.77%
Sep 30, 2023 37.50%
Jun 30, 2023 36.73%
Mar 31, 2023 31.96%
Dec 31, 2022 35.32%
Sep 30, 2022 35.60%
Jun 30, 2022 35.85%
Mar 31, 2022 35.08%
Dec 31, 2021 30.99%
API Access

Amneal Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=AMRX&period=max&api_key=YOUR_API_KEY